WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1632972 PLYMOUTH, MN

Position in AXSM

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$4,875,573

+$1,633,770 QoQ

Shares Held

19,919

+3.9% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 30 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 2.565389828806667.ToString("F0")% Shared 0.ToString("F0")% None 97.43461017119334.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. AXSM ranks #8 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc. This page	19,919	$4,875,573

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,875,573	19,919	+3.9%	Shares	Sole	2026-07-15
2026-03-31	$3,241,803	19,180	-11.8%	Shares	Sole	2026-04-08
2025-12-31	$3,973,881	21,758	+1.2%	Shares	Sole	2026-01-08
2025-09-30	$2,611,782	21,505	+4.0%	Shares	Sole	2025-10-29
2025-06-30	$2,158,576	20,678	+0.2%	Shares	Sole	2025-07-10
2025-03-31	$2,407,709	20,644	+5.2%	Shares	Sole	2025-04-16
2024-12-31	$1,660,640	19,627	-0.9%	Shares	Sole	2025-03-17
2024-09-30	$1,780,144	19,808	+4.0%	Shares	Sole	2024-10-24
2024-06-30	$1,533,847	19,054	+0.0%	Shares	Sole	2024-07-16
2024-03-31	$1,519,791	19,045	+0.7%	Shares	Sole	2024-04-15
2023-12-31	$1,505,444	18,915	—	Shares	Sole	2024-01-30
No filing history on record for this holder in this stock.